Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myelitis, Transverse × Adrenal Cortex Hormones × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Prostatic Neoplasms 5 Brain Neoplasms 4 Radiation Injuries 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hemangioma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Urogenital Neoplasms 1 Respiratory Distress Syndrome 1 Radiation Pneumonitis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Popliteal Cyst 1 Polycystic Ovary Syndrome 1 Pneumonia, Viral 1 Pneumonia 1 Optic Neuritis 1 Neoplastic Cells, Circulating 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 Myelitis, Transverse 1 Myelitis 1 Myasthenia Gravis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1

Interventions

eculizumab 3 ublituximab 1 Rituximab 1 Plasma Exchange 1 OM 89 1 N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide 1 Mitoxantrone 1 LFB-R603 1 Interferon beta-1a 1 Immunoglobulins, Intravenous 1 Blood Specimen Collection 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07100990 2026-03-11

TIMELY-PLEX

Mayo Clinic

Phase 3 Recruiting

Myelitis, Myelitis, Transverse, Optic Neuritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡